Mirum Pharmaceuticals, Inc. Business Finance Contracts & Agreements
21 Contracts & Agreements
- Indenture Agreements (1 contract)
- Investor Rights Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (1)
- Stock Agreements (9)
- Subscription Agreements (2)
- Underwriting Agreements (4)
- Description of Common Stock of the Registrant (Filed With SEC on March 15, 2024)
- Form of Subscription Agreement (Filed With SEC on August 7, 2023)
- Form of Registration Rights Agreement (Filed With SEC on July 17, 2023)
- Form of Subscription Agreement (Filed With SEC on July 17, 2023)
- Asset Purchase Agreement, dated July 16, 2023, by and between Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc (Filed With SEC on July 17, 2023)
- Indenture, dated as of April 17, 2023, between Mirum Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on April 17, 2023)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, SVB Securities LLC and Evercore Group L.L.C., dated August 9, 2022 (Filed With SEC on August 10, 2022)
- Forms of international restricted stock unit grant notice and award agreement under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan (Filed With SEC on March 9, 2022)
- Forms of international grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan (Filed With SEC on March 9, 2022)
- Mirum Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan Terms and conditions Non-U.S. Participants (Filed With SEC on March 9, 2022)
- Asset Purchase Agreement, dated November 16, 2021, by and between the Registrant and Janssen Biotech, Inc (Filed With SEC on November 19, 2021)
- Amendment No. 1 to Revenue Interest Purchase Agreement, dated September 28, 2021 (Filed With SEC on September 29, 2021)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, SVB Leerink LLC and Evercore Group L.L.C., dated December 14, 2020 (Filed With SEC on December 15, 2020)
- Forms of restricted stock unit grant notice and award agreement under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan (Filed With SEC on May 7, 2020)
- Forms of grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan (Filed With SEC on May 7, 2020)
- Description of Common Stock of the Registrant (Filed With SEC on March 12, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 6, 2020)
- Mirum Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on July 8, 2019)
- Form of Common Stock Certificate (Filed With SEC on July 8, 2019)
- Form of Underwriting Agreement (Filed With SEC on July 8, 2019)
- Investors Rights Agreement, dated November 5, 2018 (Filed With SEC on June 21, 2019)
